This November marks a major milestone for health innovation as Frontiers Health celebrates its 10th anniversary.

More than 80% of cardiac care professionals think AI can help tackle major issues facing teams, including lengthening delays ...

An unusual study presented at the European Society of Cardiology (ESC) congress in Madrid today has found that treating heart ...

Be at the forefront of the next era in evidence generation at the IMPACCT Real-World Evidence Summit West, where real-world ...

Clinical trials are designed to evaluate the safety and efficacy of new therapies or medical devices. During these trials, ...

This includes exploring the use of complement-mediators as combination therapies, discovering innovative indications where ...

The future of obesity therapeutics is being written now – be a part of it! Visit the full agenda and speakers here: ...

Gadoquatrane is being assessed by the US regulator for contrast-enhanced MRI scans of the central nervous system and other ...

Current therapies for gMG include AstraZeneca/Alexion's complement C5 inhibitor Ultomiris (ravulizumab), which needs to be ...

Nykode will boost its spending on its third major platform – designed to induce tolerance in autoimmune diseases – but a partnership with Regeneron spanning off-the-shelf cancer immunotherapies and ...

While economic evaluations remain the purview of national bodies, the JCA now mirrors the centralised approach of the ...

The EU has given Gilead the green light to market its twice-yearly pre-exposure prophylaxis (PrEP) product lenacapavir, which ...